USPTO serial 79310735
CUMEC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 13, 2022
- Examiner
- MAHMOUDI, MARIAM AZIZ
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CUMEC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kumiko Ide
Kumiko Ide Wenderoth, Lind & Ponack, L.L.P.1025 Connecticut Avenue NW, Suite 500Washington, DC 20036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment and prevention of diabetes, diabetic complication, hyperlipidemia, hyperuricemia, gout, lifestyle related metabolic and endocrine diseases, nutritional disorders, impaired glucose tolerance, metabolic syndrome, obesity and lipid disorder, hypertension, hyperglycemia, ischemic heart disease, hyperinsulinemia, arteriosclerosis, myocardial infarction, angina pectoris, aneurysm, chronic kidney disease, renal calculi, kidney disease, pyelonephritis, nephritis, urethritis, cystitis, hypercholesterolemia and high triglyceridemia, bronchitis, pulmonary emphysema and lung inflammation, abnormality of the intestinal flora, abdominal distension, peptic ulcer, intestinal disease, inflammatory disorder, irritable bowel syndrome, gastric ulcer, inflammatory bowel disease, Crohn's disease, diverticulitis, liver cirrhosis, fatty liver, diarrhea, constipation, loose stool disease, hepatic inflammation, non-alcoholic steatohepatitis, viral hepatitis, alcoholic hepatitis, dental disease, periodontal diseases, stomatitis, xerostomia and cyst, immune related diseases and abnormalities, type I, II, III, IV and V allergy, pollinosis, atopic dermatitis, psoriasis, autoimmune disease and connective tissue disease, rheumatism, osteoporosis and articular inflammation, pathogenic microbial and malignant neoplastic infections, cancer and malignant tumor, mental disorder, dementia, Alzheimer's disease, bipolar disorder, depression, anorexia, insomnia, cerebral apoplexy, cerebral infarction, autism, neuroinflammation, overwork related disease and nerve inflammation related diseases and cancers resulting from chronic inflammation, ophthalmic disease, ocular inflammation, otorhinolaryngology disease and skin inflammation; reagent paper for medical purposes; fumigants for agricultural purposes; fungicides for agricultural purposes; rodenticides for agricultural purposes; insecticides for agricultural purposes; herbicides being weedkillers; insect-repellents for agricultural purposes; antiseptics for agricultural purposes; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages for skin wounds; breast-nursing pads; cotton swabs for medical use; dental materials, namely, dental porcelain materials, materials for making dental impressions and composite materials for dental and dental technical purposes; diapers, namely, adult diapers and baby diapers; infant diaper covers; fly catching paper; mothproofing paper; lacteal flour for babies; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages for babies adapted for medical use; food for babies; dietary supplements for animals; semen for artificial insemination | ACTIVE | — |
| 016 | Paper and cardboard; printed matter, namely, manuals, newspapers, photographs, magazines, newsletters, posters, calendars and books all in the field of health | ACTIVE | — |
| 035 | Advertising and publicity services; retail store services and wholesale store services featuring processed food | ACTIVE | — |
| 041 | Educational services, namely, conducting workshops and seminars in the field of arts, crafts, sports, and general health knowledge; educational services, namely, providing a website in the field of sports and arts and crafts; instruction services in the field of arts, crafts, sports, and general health knowledge; arranging, conducting and organization of seminars in the field of arts, crafts, sports, and general health knowledge | ACTIVE | — |
| 042 | Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs | ACTIVE | — |
| 044 | Providing medical information; physical examination | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Noster Inc.
- Other trademarks owned by Noster Inc.
- Other trademarks owned by Noster Inc.
- Other trademarks in Class 005
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CUMEC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 9, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 15, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 15, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 13, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 13, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 13, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 28, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 28, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 8, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 20, 2022 | ALIE | ASSIGNED TO LIE | — |
| May 19, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 19, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 19, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 19, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 19, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 4, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 4, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 4, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 23, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 23, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 23, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 4, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 16, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 16, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 3, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 2, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 1, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 21, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 17, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 13, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |